Company Registration No. 11961976 (England and Wales)
Gmed Chempharm Co., Limited
Unaudited accounts
for the year ended 30 April 2026
Gmed Chempharm Co., Limited
Unaudited accounts
Contents
Gmed Chempharm Co., Limited
Company Information
for the year ended 30 April 2026
Company Number
11961976 (England and Wales)
Registered Office
Unit 39a St Olavs Court
City Business Centre
Lower Road
London
SE16 2XB
Accountants
LJW Accountants Limited
12 Flanders Court
Dartford
Kent
DA1 2AF
Gmed Chempharm Co., Limited
Statement of financial position
as at 30 April 2026
Cash at bank and in hand
68,655
85,280
Creditors: amounts falling due within one year
(921,420)
(763,640)
Net current assets
14,161
12,885
Called up share capital
1,000
1,000
Profit and loss account
13,161
11,885
Shareholders' funds
14,161
12,885
For the year ending 30 April 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 11 October 2026 and were signed on its behalf by
An Lai Zhang
Director
Company Registration No. 11961976
Gmed Chempharm Co., Limited
Notes to the Accounts
for the year ended 30 April 2026
Gmed Chempharm Co., Limited is a private company, limited by shares, registered in England and Wales, registration number 11961976. The registered office is Unit 39a St Olavs Court, City Business Centre, Lower Road, London, SE16 2XB.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rates of exchange ruling at the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
Amounts falling due within one year
Trade debtors
866,926
690,245
5
Creditors: amounts falling due within one year
2026
2025
Trade creditors
828,531
674,564
Taxes and social security
299
259
Loans from directors
91,469
88,229
Gmed Chempharm Co., Limited
Notes to the Accounts
for the year ended 30 April 2026
6
Average number of employees
During the year the average number of employees was 0 (2025: 0).